Compounds > rink amide resin
Page last updated: 2024-11-10

rink amide resin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Rink amide resin: does not yield protected peptide amides using the Fmoc chemical protocol [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID3369891
SCHEMBL ID2637326
MeSH IDM0204153

Synonyms (29)

Synonym
AKOS005444281
OPREA1_862543
STK368417
1,1':4',1''-terphenyl-4,4''-dicarboxylic acid
4-[4-(4-carboxyphenyl)phenyl]benzoic acid
FT-0674869
[1,1':4',1''-terphenyl]-4,4''-dicarboxylicacid
[1,1':4',1''-terphenyl]-4,4''-dicarboxylic acid
[p-terphenyl]-4,4''-dicarboxylic acid
13653-84-4
1,4-bis(4-carboxyphenyl)benzene
rink amide resin
SCHEMBL2637326
SY027719
mfcd00389774
[1,1 inverted exclamation mark :4 inverted exclamation mark ,1 inverted exclamation mark inverted exclamation mark -terphenyl]-4,4 inverted exclamation mark inverted exclamation mark -dicarboxylic acid
[1,1';4',1'']terphenyl-4,4''-dicarboxylic acid
FZTIWOBQQYPTCJ-UHFFFAOYSA-N
DTXSID60391880
p-terphenyl-4,4''-dicarboxylic acid
J-006860
CS-0110267
AC1185
CS-12888
doi:10.14272/fztiwobqqyptcj-uhfffaoysa-n.1
10.14272/FZTIWOBQQYPTCJ-UHFFFAOYSA-N.1
A856584
not available;[1,1':4',1''-terphenyl]-4,4''-dicarboxylic acid
YSWG047
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (8)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's3 (37.50)18.2507
2000's4 (50.00)29.6817
2010's1 (12.50)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 50.24

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index50.24 (24.57)
Research Supply Index2.30 (2.92)
Research Growth Index4.36 (4.65)
Search Engine Demand Index74.40 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (50.24)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other9 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
SubstanceRelationship StrengthStudiesTrialsClassesRoles
glycine
[no description available]		1.9910alpha-amino acid;
amino acid zwitterion;
proteinogenic amino acid;
serine family amino acid		EC 2.1.2.1 (glycine hydroxymethyltransferase) inhibitor;
fundamental metabolite;
hepatoprotective agent;
micronutrient;
neurotransmitter;
NMDA receptor agonist;
nutraceutical
chlorambucil
Chlorambucil: A nitrogen mustard alkylating agent used as antineoplastic for chronic lymphocytic leukemia, Hodgkin's disease, and others. Although it is less toxic than most other nitrogen mustards, it has been listed as a known carcinogen in the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (Merck Index, 11th ed). chlorambucil : A monocarboxylic acid that is butanoic acid substituted at position 4 by a 4-[bis(2-chloroethyl)amino]phenyl group. A chemotherapy drug that can be used in combination with the antibody obinutuzumab for the treatment of chronic lymphocytic leukemia.		2.2110aromatic amine;
monocarboxylic acid;
nitrogen mustard;
organochlorine compound;
tertiary amino compound		alkylating agent;
antineoplastic agent;
carcinogenic agent;
drug allergen;
immunosuppressive agent
trifluoroacetic acid
Trifluoroacetic Acid: A very strong halogenated derivative of acetic acid. It is used in acid catalyzed reactions, especially those where an ester is cleaved in peptide synthesis.. trifluoroacetic acid : A monocarboxylic acid that is the trifluoro derivative of acetic acid.		2.0310fluoroalkanoic acidhuman xenobiotic metabolite;
NMR chemical shift reference compound;
reagent
xanthenes
Xanthenes: Compounds with three aromatic rings in linear arrangement with an OXYGEN in the center ring.		2.2110xanthene
pyrroles
1H-pyrrole : A tautomer of pyrrole that has the double bonds at positions 2 and 4.. pyrrole : A five-membered monocyclic heteroarene comprising one NH and four CH units which forms the parent compound of the pyrrole group of compounds. Its five-membered ring structure has three tautomers. A 'closed class'.. azole : Any monocyclic heteroarene consisting of a five-membered ring containing nitrogen. Azoles can also contain one or more other non-carbon atoms, such as nitrogen, sulfur or oxygen.		1.9910pyrrole;
secondary amine
1,3-dimethoxybenzene
1,3-dimethoxybenzene: structure given in first source		2.0310methoxybenzenes
azides
Azides: Organic or inorganic compounds that contain the -N3 group.. azide : Any nitrogen molecular entity containing the group -N3.		2.0510pseudohalide anionmitochondrial respiratory-chain inhibitor
carbocyanines
Carbocyanines: Compounds that contain three methine groups. They are frequently used as cationic dyes used for differential staining of biological materials.		2.2110cyanine dye;
organic iodide salt		fluorochrome
dynorphins
Dynorphins: A class of opioid peptides including dynorphin A, dynorphin B, and smaller fragments of these peptides. Dynorphins prefer kappa-opioid receptors (RECEPTORS, OPIOID, KAPPA) and have been shown to play a role as central nervous system transmitters.		1.9810
ConditionIndicatedRelationship StrengthStudiesTrials